Loading...
Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies
Background. Phase I/II studies in human immunodeficiency virus (HIV)–infected patients receiving antiretroviral therapy have shown that a single cycle of 3 weekly subcutaneous (s/c) injections of recombinant human interleukin 7 (r-hIL-7) is safe and improves immune CD4 T-cell restoration. Herein, we...
Na minha lista:
| Udgivet i: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4826452/ https://ncbi.nlm.nih.gov/pubmed/26908786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw065 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|